This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción URTA
Urteste S.A. engages in the research and development of diagnostic tests for cancers.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Urteste S.A.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | zł114.00 |
| 52 Week High | zł118.00 |
| 52 Week Low | zł101.00 |
| Beta | 0 |
| 1 Month Change | 3.64% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 3.64% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| URTA | PL Biotechs | Mercado PL | |
|---|---|---|---|
| 7D | 2.7% | 0.7% | 3.5% |
| 1Y | n/a | -17.4% | 27.4% |
Rentabilidad vs. Industria: Insufficient data to determine how URTA performed against the Polish Biotechs industry.
Rentabilidad vs. Mercado: Insufficient data to determine how URTA performed against the Polish Market.
Volatilidad de los precios
| URTA volatility | |
|---|---|
| URTA Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Precio estable de las acciones: URTA has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine URTA's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2021 | n/a | Grzegorz Stefanski | www.urteste.com |
Resumen de fundamentos de Urteste S.A.
| Estadísticas fundamentales de URTA | |
|---|---|
| Capitalización bursátil | zł129.99m |
| Beneficios(TTM) | zł0 |
| Ingresos (TTM) | n/a |
n/a
Ratio precio-beneficio (PE)n/a
Ratio precio-ventas (PS)¿Está URTA sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de URTA | |
|---|---|
| Ingresos | zł0 |
| Coste de los ingresos | zł0 |
| Beneficio bruto | zł0 |
| Otros gastos | zł0 |
| Beneficios | zł0 |
Últimos beneficios comunicados
n/a
Próxima fecha de beneficios
Aug 11, 2023
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado URTA a largo plazo?
Ver rendimiento histórico y comparativa